Azala

New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges

This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic...

Deskribapen osoa

Gorde:
Egile nagusia: Bakillah, Ahmed
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2021
Gaiak:
QH301-705.5
Q1-390
apolipoprotein
lipids
risk stratification
proprotein convertase subtilisin-kexin type 9 (PCSK9)
vaspin
sphingolipids
PCSK9
ceramides
atrial fibrillation
circular RNA
STEMI
cholesterol
lipoproteins
cardiovascular disease (CVD)
coronary artery bypass grafting
atherosclerosis
statin
LDL subfractions
acute kidney injury
dyslipidemia
gene expression
NSTEMI
NAFLD
hyperlipidemia
nonstatin
cholesteryl ester transfer protein
low-density lipoprotein cholesterol
anacetrapib
HDL
acute coronary syndrome
miRNA
cardiovascular risk
pleiotropic actions
genetic
ABCA1
sdLDL
cardiovascular disease
proprotein convertase subtilisin/kexin type 9
inclisiran
reverse cholesterol transport
sterol
small interfering RNA (siRNA)
RNA-binding proteins
cardiovascular diseases
NASH
low-density lipoprotein-cholesterol (LDL-C)
stroke
nutrigenetics
type 2 diabetes
statins
sphingomyelin
hepatic fibrosis
diabetes
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
Sarrera elektronikoa:42589
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Gaia:This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.

Antzeko izenburuak